Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, Stuart J., Ezekowitz, Michael D., Yusuf, Salim, Eikelboom, John, Oldgren, Jonas, Parekh, Amit, Pogue, Janice, Reilly, Paul A. +12 more·2009·New England Journal of Medicine
DOI 10.1056/nejmoa0905561

Cited by (1,022)

Items 601–700 of 1,022

  1. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications
    Jayasree Pillarisetti, Yeruva Madhu Reddy, Sampath Gunda, Vijay Swarup, Randall J. Lee, Abdi Rasekh, Rodney Horton, Ali Massumi, Jie Cheng, Krzysztof Bartuś et al. · 2015 · Heart Rhythm
  2. Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage Among Individuals With Associated Diagnosis of Atrial Fibrillation
    Jonathan L. Thigpen, Chrisly Dillon, Kristen Forster, Lori E. Henault, Emily Kate Quinn, Yorghos Tripodis, Peter B. Berger, Elaine M. Hylek, Nita A. Limdi · 2015 · Circulation Cardiovascular Quality and Outcomes
  3. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke
    Jonathan Chong Hsu, Thomas M. Maddox, Kevin F. Kennedy, David F. Katz, Lucas Marzec, Steven A. Lubitz, Anil K. Gehi, Mintu P. Turakhia, Gregory M. Marcus · 2016 · Journal of the American College of Cardiology
  4. Heart Failure as a Risk Factor for Stroke
    Woohyeun Kim, Eung Ju Kim · 2018 · Journal of Stroke
  5. Inappropriate Use of Oral Anticoagulants for Patients With Atrial Fibrillation
    Masaharu Akao, Yeong‐Hwa Chun, Masahiro Esato, Mitsuru Abe, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, on behalf of the Fushimi AF Registry Investigators · 2014 · Circulation Journal
  6. Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation [RETIRED]
    Antonio Culebras, Steven Russell Messe, Seemant Chaturvedi, Carlos S. Kase, Gary Gronseth · 2014 · Neurology
  7. Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Hyunmee Kim, Hyeongsoo Kim, Seong-Kyung Cho, Jin‐Bae Kim, Boyoung Joung, Changsoo Kim · 2018 · Korean Circulation Journal
  8. Control de la anticoagulación en pacientes con fibrilación auricular no valvular asistidos en atención primaria en España. Estudio PAULA
    Vivencio Barrios, Carlos Escobar, Luís Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García · 2015 · Revista Española de Cardiología
  9. Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents
    Jeremy S. Paikin, Douglas S. Wright, Mark Andrew Crowther, Shamir R. Mehta, John W. Eikelboom · 2010 · Circulation
  10. Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?
    Marco Proietti, Elisa Guiducci, Paola Cheli, Gregory Y.H. Lip · 2017 · Stroke
  11. The Significance of Drug–Drug and Drug–Food Interactions of Oral Anticoagulation
    Pascal Vranckx, Marco Valgimigli, Hein Heidbüchel · 2018 · Arrhythmia & Electrophysiology Review
  12. Oral anticoagulation use by patients with atrial fibrillation in Germany
    Thomas Wilke, Antje Groth, S. Mueller, M. Pfannkuche, Frank Verheyen, Roland Linder, Ulf Maywald, Thomas Kohlmann, You‐Shan Feng, GÜNTER E. BREITHARDT et al. · 2012 · Thrombosis and Haemostasis
  13. Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation
    Pamela Kay Mason, Douglas E. Lake, John Dimarco, John Ferguson, James Michael Mangrum, Kenneth C. Bilchick, Liza Prudente Moorman, Joseph Randall Moorman · 2012 · The American Journal of Medicine
  14. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice
    Marijana Vaso Tadic, Cesare Cuspidi · 2015 · Archives of cardiovascular diseases
  15. New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs
    Renato D. Lópes, Elaine M. Hylek, David A. Garcia · 2010 · Thrombosis and Haemostasis
  16. Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
    Jens Lutz, Kerstin Jurk, Helmut Schinzel · 2017 · International Journal of Nephrology and Renovascular Disease
  17. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Katsushige Ono, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Circulation Journal
  18. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
    Mike Ufer · 2010 · Thrombosis and Haemostasis
  19. Failure of Anticoagulant Thromboprophylaxis
    Wendy Lim, Maureen O. Meade, François Lauzier, Ryan Zarychanski, Sangeeta Mehta, François Lamontagne, Peter Dodek, Lauralyn McIntyre, Richard Hall, Diane Heels‐Ansdell et al. · 2014 · Critical Care Medicine
  20. High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
    Ziad Hijazi, Agneta G Siegbahn, Ulrika Andersson, Christopher Bull Granger, John Hunter Alexander, Dan Atar, Bernard John Gersh, Puneet Mohan, Veli‐Pekka Harjola, John David Horowitz et al. · 2013 · Circulation
  21. Atrial fibrillation and stroke
    Sylvia E. Choi, Dimitrios Sagris, Andrew M. Hill, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2022 · Expert Review of Cardiovascular Therapy
  22. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department
    Ian Gilmour Stiell, Laurent Macle · 2011 · Canadian Journal of Cardiology
  23. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
    Tatjana Potpara, Charles Joseph Ferro, Gregory Y.H. Lip · 2018 · Nature Reviews Nephrology
  24. Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement
    David Jochheim, Marco Barbanti, Giuliana Capretti, Giulio Giuseppe Stefanini, Alexander Hapfelmeier, Magda Zadrozny, Moritz Baquet, Julius Fischer, Hans Diogenes Theiss, Denise Todaro et al. · 2019 · JACC: Cardiovascular Interventions
  25. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Scott Pearson, Richard Troughton, A Mark Richards · 2011 · New England Journal of Medicine
  26. Adverse prognosis of incidentally detected ambulatory atrial fibrillation
    Carlos Martínez, Anja Katholing, Saul Benedict Freedman · 2014 · Thrombosis and Haemostasis
  27. Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Concomitant Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-Analysis of Randomized Trials
    Qinmei Xiong, Yee Cheng Lau, Keitaro Senoo, Deirdre A. Lane, Kui Hong, Gregory Y.H. Lip · 2015 · European Journal of Heart Failure
  28. Evolving use of new oral anticoagulants for treatment of venous thromboembolism
    Calvin H. Yeh, Peter L. Gross, Jeffrey Ian Weitz · 2014 · Blood
  29. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
    Anuraag R Kansal, Sonja V. Sorensen, Ray Gani, Paul J. Robinson, Feng Pan, Jonathan M Plumb, Martín Cowie · 2012 · Heart
  30. Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
    Peter Higgins, Peter W. Macfarlane, Jesse Dawson, Gordon T. McInnes, Peter Langhorne, Kennedy R. Lees · 2013 · Stroke
  31. Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)
    Stuart J. Connolly, John W. Eikelboom, Paul Dorian, Stefan Hans Hohnloser, Daniel D. Gretler, Uma Sinha, M. D. Ezekowitz · 2013 · European Heart Journal
  32. Why do we need observational studies of everyday patients in the real-life setting?: Table 1
    Alexander Thomas Cohen, Shinya Goto, Karen Ingrid Schreiber, Christian Tobias Torp-Pedersen · 2015 · European Heart Journal Supplements
  33. Spontaneous Intracerebral Hemorrhage: Management
    Jun Yup Kim, Hee‐Joon Bae · 2017 · Journal of Stroke
  34. Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
    Ying Bai, Hai Deng, Alena Shantsila, Gregory Y.H. Lip · 2017 · Stroke
  35. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system
    Janet M. Schnee, Kathy H. Fraeman, Kimberly Siu, Matthew W. Reynolds, Jenna M. Collins, Eric Schwartzman, Todd C. Villines · 2015 · Thrombosis and Haemostasis
  36. Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment
    Jochen Graff, Sebastian Harder · 2013 · Clinical Pharmacokinetics
  37. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
    Giulia Renda, Fabrizio Ricci, Robert Patrick Giugliano, Raffaele De Caterina · 2017 · Journal of the American College of Cardiology
  38. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry
    Martín Ruiz Ortiz, Javier Muñiz, P Rana Miguez, Inmaculada Roldán, Francisco R. Marín, María Asunción Esteve‐Pastor, Angel R. Cequier, Manuel Martínez‐Sellés, Vicente Bertoméu, Manuel P. Anguita et al. · 2017 · EP Europace
  39. Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
    A. John Camm, Keith A.A. Fox · 2018 · Open Heart
  40. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation
    Katsiaryna Bykov, Dorothee B. Bartels, Krista F. Huybrechts, Kristina Zint, Sebastian Schneeweiß, John D. Seeger · 2015 · Thrombosis and Haemostasis
  41. Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
    Julian Ilcheff Borissoff, Jeroen J. T. Otten, Sylvia Heeneman, Peter J. A. Leenders, René van Oerle, Oliver Soehnlein, Sarah T.B.G. Loubele, Karly Hamulyák, Tilman M. Hackeng, Mat J.A.P. Daemen et al. · 2013 · PLoS ONE
  42. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
    Daniel Caldeira, Filipe Brogueira Rodrigues, Márcio Barra, Ana Teresa Santos, Daisy Abreu, Nilza Gonçalves, Fausto José Pinto, Joaquim José Ferreira, João N. Costa · 2015 · Heart
  43. Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
    So‐Ryoung Lee, Hyun‐Jung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Gregory Y.H. Lip · 2019 · Journal of the American College of Cardiology
  44. Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study
    Saket Sanghai, Chi Hang Wong, Ziyue Wang, Pia H. Clive, Wenisa Tran, Molly E. Waring, Robert Joel Goldberg, Robert Hayward, Jane S. Saczynski, David D. McManus · 2020 · Journal of the American Heart Association
  45. Edoxaban: a focused review of its clinical pharmacology
    Gregory Y.H. Lip, Giancarlo Agnelli · 2014 · European Heart Journal
  46. Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
    Kyla R. Rodgers, Richard C. Chou · 2016 · Biotechnology Advances
  47. Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients ― Fushimi AF Registry ―
    Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe et al. · 2017 · Circulation Journal
  48. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
    Darae Ko, Kueiyu Joshua Lin, Lily Gui Bessette, Su Been Lee, Allan J. Walkey, Susan C. Cheng, Erin Kim, Robert J. Glynn, Dae Hyun Kim · 2022 · JAMA Network Open
  49. Pregnancy and Stroke Risk in Women
    Jessica Tate, Cheryl Bushnell · 2011 · Women s Health
  50. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
    Lars Hvilsted Rasmussen, Torben Bjerregaard Larsen, Tina Graungaard, Flemming Skjøth, Gregory Y.H. Lip · 2012 · BMJ
  51. Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation
    Wobo Bekwelem, Stuart J. Connolly, Jonathan L. Halperin, Selçuk Adabağ, Sue Duval, Susan Chrolavicius, Janice M. Pogue, Michael D. Ezekowitz, John W. Eikelboom, Lars C. Wallentin et al. · 2015 · Circulation
  52. The Use of Dabigatran Immediately After Atrial Fibrillation Ablation
    Roger A. Winkle, R. Hardwin Mead, Gregory Engel, Melissa H. Kong, Rob A. Patrawala · 2011 · Journal of Cardiovascular Electrophysiology
  53. Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation
    Michael Markl, Daniel C. Lee, Nicholas M. Furiasse, Maria L. Carr, Charles Elliott Foucar, Jason Ng, James Carr, Jeffrey J. Goldberger · 2016 · Circulation Cardiovascular Imaging
  54. Early start of DOAC after ischemic stroke
    David Julian Seiffge, Christopher Traenka, Alexandros A. Polymeris, Lisa Hert, Nils Peters, Philippe A. Lyrer, Stefan T. Engelter, Leo Hermann Bonati, Gian Marco De Marchis · 2016 · Neurology
  55. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
    Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Elaine M. Hylek, Renato D. Lópes et al. · 2017 · European Heart Journal
  56. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
    Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, Valeria Coluccio, Alessandra Marrazzo, Afroditi Athanasiou, Maria Di Girolamo, Cinzia Cappi, Marco Marietta, Mariano Capitelli · 2022 · Advances in Therapy
  57. Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
    Tomas Forslund, Björn Wettermark, Paul Hjemdahl · 2015 · European Journal of Clinical Pharmacology
  58. Drug–Drug Interactions with Direct Oral Anticoagulants
    Kathrin Isabelle Foerster, Simon A. Hermann, Gerd Mikus, Walter E. Haefeli · 2020 · Clinical Pharmacokinetics
  59. Decrease in the oral bioavailability of dabigatran etexilate after co‐medication with rifampicin
    Sebastian Härtter, Michael Koenen‐Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer, Paul A. Reilly · 2012 · British Journal of Clinical Pharmacology
  60. Pharmacogenetics of warfarin: challenges and opportunities
    Ming Ta Michael Lee, Teri E. Klein · 2013 · Journal of Human Genetics
  61. Initial Experience With a Novel Percutaneous Left Atrial Appendage Exclusion Device in Patients With Atrial Fibrillation, Increased Stroke Risk, and Contraindications to Anticoagulation
    Ali Massumi, Mihail Gabriel Chelu, Alireza Nazeri, Stephen May, Hamid Afshar-Kharaghan, Mohammad Saeed, Mehdi Razavi, Abdi Rasekh · 2013 · The American Journal of Cardiology
  62. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Gboyega Adeboyeje, Gosia Sylwestrzak, John J. Barron, Jeff White, Alan Rosenberg, Jacob Abarca, Geoffrey Crawford, Rita F. Redberg · 2017 · Journal of Managed Care & Specialty Pharmacy
  63. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
    Sylvie Perreault, Simon de Denus, Brian White‐Guay, Robert Côté, Mireille E. Schnitzer, Marie‐Pierre Dubé, Marc Dorais, Jean‐Claude Tardif · 2019 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  64. Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban
    Wei Zhou, Markus Zorn, Peter Paul Nawroth, Ulf Buetehorn, Elisabeth Perzborn, Stefan Heitmeier, Roland C. Veltkamp · 2013 · Stroke
  65. NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis
    Tim Hicks, Fiona J. Stewart, Anne Eisinga · 2016 · Open Heart
  66. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1
    Tobias Petzold, Manuela Thienel, Lisa Dannenberg, Philipp Mourikis, Carolin Helten, Aysel Ayhan, René M’Pembele, Alina Achilles, Kajetan Trojovky, Daniel Konsek et al. · 2019 · Circulation Research
  67. Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation
    Dae Hyun Kim, Ajinkya M Pawar, Joshua J. Gagne, Lily Gui Bessette, Hemin Lee, Robert J. Glynn, Sebastian Schneeweiß · 2021 · Annals of Internal Medicine
  68. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
    Michelle Z. Gurvitz, Eric V. Krieger, Stephanie Fuller, Leslie L. Davis, Michelle Maya Kittleson, Jamil Aboulhosn, Elisa A. Bradley, Jonathan Buber, Curt J. Daniels, Konstantinos Dimopoulos et al. · 2025 · Journal of the American College of Cardiology
  69. Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence
    Joseph P. Broderick, Jordan Bonomo, Brett M. Kissela M. D, Jane C. Khoury, Charles J. Moomaw, Kathleen Alwell, Daniel Woo, Matthew L. Flaherty, Pooja Khatri, Opeolu M Adeoye et al. · 2011 · Stroke
  70. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
    Meena P. Rao, Dragoş Vinereanu, DANIEL M. WOJDYLA, John Hunter Alexander, Dan Atar, Elaine M. Hylek, Michael Hanna, Lars C. Wallentin, Renato D. Lópes, Bernard John Gersh et al. · 2017 · The American Journal of Medicine
  71. Deep vein thrombosis
    Matthew James Stubbs, Maria Mouyis, Mari R. Thomas · 2018 · BMJ
  72. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
    Yi‐Hsin Chan, Hsin‐Fu Lee, Lai‐Chu See, Hui‐Tzu Tu, Tze‐Fan Chao, Yung‐Hsin Yeh, Lung‐Sheng Wu, Chi-Tai Kuo, Shang‐Hung Chang, Gregory Y.H. Lip · 2019 · CHEST Journal
  73. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
    Tze‐Fan Chao, Chia‐Jen Liu, Jo‐Nan Liao, Kang-Ling Wang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung et al. · 2016 · Circulation
  74. Antithrombotic Agents
    Noel Chan, Jeffrey Ian Weitz · 2019 · Circulation Research
  75. Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats
    Ton Lisman, Pieter Willem Kamphuisen, Patrick Grant Northup, Robert Jack Porte · 2013 · Journal of Hepatology
  76. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes
    Laurent Azoulay, Sophie Dell’Aniello, Teresa A. Simon, Christel Renoux, Samy Suissa · 2013 · European Heart Journal
  77. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
    Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, Pål Falck, Oddvar Solli, Christian Jonasson · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
  78. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials
    George Ntaios, Vasileios Papavasileiou, Hans-Chris Diener, Konstantinos P. Makaritsis, Patrik Michel · 2017 · International Journal of Stroke
  79. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
    Dipak Kotecha, GÜNTER E. BREITHARDT, A. John Camm, Gregory Y.H. Lip, Ulrich Schotten, Anders Ahlsson, Davíð O. Arnar, Dan Atar, Angelo Auricchio, Jeroen Joost Bax et al. · 2018 · EP Europace
  80. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial
    Chris Wilkinson, Jianhua Wu, Samuel D. Searle, Oliver M. Todd, Marlous Hall, Vijay Kunadian, Andrew Paul Clegg, Kenneth J. Rockwood, Chris P Gale · 2020 · BMC Medicine
  81. Atrial Fibrillation and Ischemic Stroke: A Clinical Review
    Ibrahim Migdady, Andrew Russman, Andrew Blake Buletko · 2021 · Seminars in Neurology
  82. Poststroke atrial fibrillation: Cause or consequence?
    Luciano Alberto Sposato, Patricia Mariana Riccio, Vladimir Hachinski · 2014 · Neurology
  83. Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study
    PASSMAN, ROD, LEONG‐SIT, PETER, ANDREI, ADIN‐CRISTIAN, HUSKIN, ANNA, TOMSON, TODD T., BERNSTEIN, RICHARD, ELLIS, ETHAN, WAKS, JONATHAN W., ZIMETBAUM, PETER · 2016 · Journal of Cardiovascular Electrophysiology
  84. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery
    Etem Caliskan, Ayhan Sahin, Murat Yılmaz, Burkhardt Seifert, Ricarda Hinzpeter, Hatem Alkadhi, James L. Cox, Tomáš Holubec, Diana Reser, Volkmar Falk et al. · 2017 · EP Europace
  85. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
    Amitava Banerjee, Valerio Benedetto, Phillip Gichuru, Jane Burnell, Sotiris Antoniou, RICHARD JOHN SCHILLING, William David Strain, Ronan P. Ryan, Caroline Leigh Watkins, Tom P Marshall et al. · 2019 · Heart
  86. A practical approach to the management of cerebral amyloid angiopathy
    Mariel G. Kozberg, Valentina Perosa, M. Edip Gurol, Susanne J. van Veluw · 2020 · International Journal of Stroke
  87. Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -
    Masatsugu Hori, Stuart J. Connolly, Michael D. Ezekowitz, Paul A. Reilly, Salim Yusuf, Lars C. Wallentin, the RE-LY Investigators · 2011 · Circulation Journal
  88. How I treat target-specific oral anticoagulant–associated bleeding
    Deborah M. Siegal, David A. Garcia, Mark Andrew Crowther · 2014 · Blood
  89. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
    Tze‐Fan Chao, Kang-Ling Wang, Chia-Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung, Jo‐Nan Liao et al. · 2015 · Journal of the American College of Cardiology
  90. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
    Joëlle Kefer, Apostolos Tzikas, Xavier Freixa, Samera Shakir, Sameer A. Gafoor, Jens Erik Nielsen‐Kudsk, Sérgio Luis Berti, Gennaro Santoro, Adel Aminian, Ulf Landmesser et al. · 2016 · International Journal of Cardiology
  91. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
    Rahul Aggarwal, Christian Thomas Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric Alexander Secemsky et al. · 2023 · Circulation
  92. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
    Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Walter E. Smalley, James R. Daugherty, William D. Dupont, C. Michael Stein · 2016 · Gastroenterology
  93. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events
    Natalia S. Rost, Robert Patrick Giugliano, Christian Thomas Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew David Norden, Scott B. Silverman, Aneesh B. Singhal, José Carlos Nicolau, Bhupathi SomaRaju et al. · 2016 · Stroke
  94. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
    Renato D. Lópes, Patrícia O. Guimarães, Brad J. Kolls, DANIEL M. WOJDYLA, Cheryl Bushnell, Michael Hanna, J. Donald Easton, Laine Elliott Thomas, Lars C. Wallentin, Sana M. Al‐Khatib et al. · 2017 · Blood
  95. Silent brain infarcts impact on cognitive function in atrial fibrillation
    Michael Kühne, Philipp Krisai, Michael Coslovsky, Nicolas Rodondi, Andreas S. Müller, Jürg Hans Beer, Peter Ammann, Angelo Auricchio, Giorgio Moschovitis, Daniel Hayoz et al. · 2022 · European Heart Journal
  96. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Vanessa Roldán, Francisco R. Marín, Sergio Manzano‐Fernández, Hermógenes Fernández, Pilar Gallego, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip · 2013 · Thrombosis and Haemostasis
  97. Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation
    Iqbal Jaffer, Alan R. Stafford, James C. Fredenburgh, Richard Paul Whitlock, Noel Chan, Jeffrey Ian Weitz · 2015 · Journal of the American Heart Association
  98. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
    Chris G Cameron, Doug Coyle, Trevor A. Richter, Shannon Kelly, Kasandra Gauthier, Sabine Steiner, Marc Carrier, Kathryn Coyle, Annie Bai, Kristen Moulton et al. · 2014 · BMJ Open
  99. Thrombin as a multi-functional enzyme
    Michael Schwameis, Andrew D. Blann, Christine Mannhalter, Bernd Jilma, Jolanta Maria Siller-Matula · 2011 · Thrombosis and Haemostasis
  100. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin
    Matthew J. Price, Vivek Yerrapu Reddy, Miguel Valderrábano, Jonathan L. Halperin, Douglas N Gibson, Nicole T. Gordon, Kenneth Christopher Huber, David R. Holmes · 2015 · JACC: Cardiovascular Interventions